D-0113-2018 Class I Terminated
FDA drug recall D-0113-2018 was initiated by Advanced Pharma Inc. on Jun 9, 2017 and is designated Class I. Reason for recall: Subpotent Drug: found to be below the specification for labeled assay. The recall status is terminated (terminated Apr 3, 2019). Affected quantity: 550 syringes.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 27, 2017
- Initiation Date
- Jun 9, 2017
- Termination Date
- Apr 3, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 550 syringes
Product description
NitroGlycerin 1 mg/10 mL in 5% Dextrose Inj, USP QS 10mL (100 mcg per mL), 10 mL Sterile single dose syringe, packaged in 5 x 5 (TWENTY FIVE) syringes per box, Rx only, Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054, NDC 15082-818-61.
Reason for recall
Subpotent Drug: found to be below the specification for labeled assay.
Distribution pattern
Nationwide in the USA to hospitals and medical facilities.
Code information
Lot: 4/17/17 0857 81861S, BUD 08/15/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0113-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026